It is my pleasure to introduce our second Newsletter for 2002 and to
advise you of some important changes that have occurred in the last couple
of months. After nearly 4 years of service to the Association Cathy Dart,
our Welfare Officer, has resigned to further her career in other areas.
As many of you well know, Cathy has been a tireless worker and has become
a confidant and friend to many families and support workers. We will miss
Cathy very much, and I know that you join with me in wishing her every
success in her future endeavours.
To fill Cathy's shoes, we welcome Mrs. Kellie Chenoweth as our new Welfare
Officer and we look forward to benefiting from Kellie's experience.
As advised in our last Newsletter, we decided to seek the services of
a third Welfare Officer and have been fortunate in obtaining the services
of Mrs. Tracey Beckwith to fill this part-time position.
Welcome Tracey and Kellie!
This expansion to our Welfare staff will not only provide a better service
to our families, but will also allow the Welfare staff to spend more time
in regional areas.
I am also pleased to announce that the Townsville Support Group has been
operating for 10 years. An Anniversary Dinner was held at the Townsville
RSL Club on Friday the 12th April to celebrate the achievements of the
Group during that time.
Mrs. Alison Hopgood, who was the Administration Officer of the Association
in 1992, travelled to Townsville to represent the Association and to highlight
the milestones achieved by the Group. Certificates of Appreciation were
presented to inaugural members who are still serving on the Townsville
Committee. Congratulations to Bill and Margaret Abraham, Dick and Shirley
Abraham, Tom and Jean Paterson, Bill Klaassen and Vic Wakefield for their
outstanding service.
We congratulate the Townsville Group for a "job well done"
and thank all members for their contribution to the Association during
the last 10 years - well done.
And so, dear friends, as you can see, we maintain a positive
outlook for the future. Until next time, keep smiling.
As you will have read in Ray's article, we were sad to farewell Cathy
Dart in March. I join with Ray and our families and staff in wishing Cathy
every success in the future, and add my thanks to her for her commitment
and loyalty during her time with us.
Over the next few months, many of you will meet with our new Welfare
staff. Prior to Cathy's resignation, the Management Committee had decided
to employ a part-time Welfare Officer to work 24 hours per week. The advertisement
created a lot of interest and we finally appointed Tracey Beckwith to
fill this position. During the interviewing process we met Kellie Chenoweth
and she has been appointed to replace Cathy. In our next Newsletter, both
Kellie and Tracey will introduce themselves.
The Management Committee thought long and hard over appointing a part-time
worker to be based in Brisbane. Various ways in which we could better
service regional areas were considered - one option was to co-employ with
other support agencies in Townsville. However, for a variety of reasons,
none of the proposals proved to be viable. One of the factors influencing
our decision was from a financial point of view. Providing an office for
a worker based in regional Queensland was going to be quite expensive.
Once the new staff members are trained and comfortable in their individual
roles, both Kellie and Gwen, with Tracey holding the fort in Brisbane,
will undertake regional visits.
I will have attended the National HD Meeting and Seminar in Freemantle,
WA in April. These meetings provide an opportunity for State delegates
to interact and liaise, discussing a wide range of topics and issues.
Each State operates independently so there are quite a lot of differences
in service provision, and it is at meetings such as these that we share
our successes and failures.
Kindest regards to you all.
We were shocked to hear of the sudden death on the 22nd March, 2002 of
founder and former Executive Officer of the Huntington Society of Canada,
Ralph Walker. He was 63.
His unrelenting drive to help those affected by Huntington's was a result
of watching his cousin suffer with the disease. As a high school teacher
and guidance counsellor, Ralph also met students whose families were affected
by Huntington's.
In 1977 he left his career in education to work full time as the Executive
Director of the HSC until his retirement in 1998. However, Ralph continued
to represent Canada at the IHA Meetings and in 1999 was made an Honorary
Board Member of the IHA which he also helped found in 1974.
Ralph's contribution to the Huntington community can never be expressed
adequately in words. Through his leadership, the Huntington Society of
Canada has provided a wonderful model for all HD Associations throughout
the world.
We will always be indebted to Ralph for his professionalism and support.
We appreciate and shall never forget his willingness to share resources
and ideas.
Our thoughts are with his wife and friend, Ariel, and his children and
grandchildren at this time.
Dear Friends
This has been an extremely difficult article for me to write and it is
with great regret that I say it will be my last for the time being at
least, 'never say never '. Many of you will already be aware that
I have accepted a new position in Psychology and resigned as Welfare Officer
for the AHDA (Q).
I have been an employee of the Association for almost four years and
dragging myself away has been difficult. Fresh from uni in 1998 I was
delighted to be offered the position of Welfare Officer for the AHDA (Q).
This position has grown and developed as the Association has expanded
providing a huge range of experiences and opportunities for me to develop
my skills. I only hope that the majority of the people I worked with have
experienced similar achievements.
Early this year the Association advertised a new position for a part-time
Welfare Officer to be based in Brisbane. The response to the initial advertisement
was overwhelming and we were delighted at the level of expertise and training
that our advertisement had attracted. It was this response that inspired
me to reconsider my own career development and some feelings that perhaps
it was time for me to expand my knowledge again. I knew that my position
and role within the Association would easily be filled by a well-educated
and highly motivated professional. I also believed there would be benefits
in efficiency for the Association to introduce and train two new employees
at the same time. Two Welfare Officers working together with Gwen to assimilate
information and 'learn the ropes' would minimise any interruption to the
welfare services.
The Association has been very fortunate in securing the employment of
Kellie and Tracey and I am very confident that these two energetic professionals
will provide an excellent service. I wish both Kellie and Tracey all the
best and congratulate them on their achievements so far.
On reflection this newsletter entry is a very different one to the February
edition and I apologise profusely to anyone who has been inconvenienced
by the sudden changes to the Welfare staff.
I would like to thank all of the families and the professionals who I
have worked with for their perseverance, support and patience (you know
what I mean!). Without your ongoing enthusiasm for the HD Welfare Service
my work would certainly have been a lot more difficult. I would also like
to thank the administration staff and committee for their enduring support
and assistance. For a small gang you 'do a big job' very very well!
Keep up the good work all of you, take greatest care and I'll be hoping
for the best of everything for each and every one of you. Kindest Regards,
Dr Neil Mahant, the first recipient of a grant from the NSW Association's
Research Grants Program has provided the following update of research
being carried out at Westmead Hospital.
It was announced at the Annual General Meeting that the Committee has
decided to fund Dr Mahant for a further twelve months.
Neurophysiology Study
To date, 38 subjects have participated in the study. The data analysis
phase is about to commence. The aim of this phase is to determine the
feasibility of serial assessments of the participants already studied.
Publication of this data is expected soon. Some early findings were presented
at a Neurophysiology conference in March 2001
We are extending the neurophysiological analysis to look at the prevalence,
clinical and neurophysiological features of tremor in HD. Occasionally
people with tremor due to HD have been reported, but there has been no
systematic study of tremor and no description of its neurophysiological
characteristics.
Gait Study
Ethical approval for the study was gained early this year. Our collaborators
in Melbourne are planning to come to Sydney in the near future.
MRI Study
The voxel-based morphometric analysis of brain MRIs in pre-clinical HD
was presented at the recent World Federation of Neurology Research Group
meeting in Copenhagen, and was well received. We demonstrated the VBM
could detect very subtle changes in this group, and that the left side
seemed to be more severely affected. These are novel and important findings.
A manuscript has been accepted for publication in a major neurological
journal (Brain).
We are planning to rescan the same group of subjects to assess the ability
of this technique to detect the rate of progression in pre-clinical HD.
Clinical Study
The Huntington Study Group has a large database of the Unified HD Rating
Scale (UHDRS) assessments. They have sent us scores on over 1000 people,
many of whom have had regular assessments over more than 2 years. We hope
to determine which parts of the scale are best at monitoring the disease
over time, and to examine whether the mode of onset (ie motor or cognitive/psychiatric)
have an effect on the rate of disease progression. I am currently engaged
in the statistical analysis of this data, and am planning to present the
results at the American Academy of Neurology conference in April.
Summary
We hope that there will be treatments that slow, or even halt, the progression
of HD. Our work will provide important information for the design of treatment
trials, so that they can give us more reliable results sooner. The neurophysiology
study will give insight into how different pathways are affected during
the course of HD. The tremor study will document the prevalence and severity
of tremor, and help to establish the causes (and therefore suggest possible
treatments) of tremor in HD.
Many thanks to those of you who have taken part in the studies. Thanks
also to the AHDA (NSW) for their generous support. I am hoping to submit
the Ph.D. thesis by the end of the year.
New Progress Results in Huntington's Disease Research
Source: Huntington's Disease Society of America - dlovesky@hdsa.org
New York, NY March 19, 2002 - In a study published in the March 14th
issue of the scientific journal, Neuron, HDSA grant recipient Lynn Raymond,
Ph.D., in collaboration with HDSA Coalition for the Cure investigator
Michael Hayden, M.D., Ph.D. and others at the University of British Columbia
in Vancouver, found that selective neurodegeneration in HD may be due
in part to the role specific molecules called NMDA receptors play in cell
death.
Using HD mouse models developed by Dr. Hayden, that express full-length
mutant huntingtin, researchers found that the medium spiny neurons in
the mice expressing mutant huntingtin were more vulnerable to the NMDA
receptor agonist, quinolinic acid, than neurons in mice expressing normal
huntingtin. By contrast, there was no difference in vulnerability to non-NMDA
glutamate receptors in mice expressing wild-type (normal) huntingtin and
those expressing huntingtin with an expanded polyglutamine (72 glutamines).
Different forms of NMDA receptors are present on most neurons and are
some of the molecules that enable neurons to respond to the most common
excitatory neurotransmitter in the brain - glutamate. However too much
glutamate, or abnormal responses to glutamate, can cause a form of cell
death "excitotoxicity".
The results of Lynn Raymond and Michael Hayden's collaboration are significant
in that they provide evidence that excitotoxicity may be relevant to HD.
Excitotoxicity has previously been proposed as a model for cell death
in HD, because even in normal mice or rats, excitotoxins such as quinolinic
acid (which are agonists or activators of NMDA receptors) produce a pattern
of cell death similar to that seen in HD. However, the CARE-HD study tested
an NMDA receptor blocker called remacemide, and found it had no beneficial
effects on the progression of HD. The Raymond/Hayden study suggests that
blocking certain subsets of NMDA receptors may prove more effective, since
a specific subset of NMDA receptors appear to be partly responsible for
selective vulnerability in medium spiny neurons, leading to degeneration
in the HD mouse model.
Huntington's Disease (HD) is a hereditary degenerative brain disorder
that is characterized by involuntary movements, personality changes, dementia
and early death. There is currently no effective treatment or cure. But
there is hope. In 1993, scientists located the gene that causes HD on
the short arm of chromosome 4. HD has now become one of the most widely
studied of the polyglutamine repeat diseases and is considered a "model"
for other neurodegenerative disorders since cell death has been found
in at least nine distinct neurodegenerative diseases that are hallmarked
by an expanded CAG repeat.
The Huntington's Disease Society of America funds both basic and clinical
HD research through an aggressive program that includes the HDSA Coalition
for the Cure, a uniquely collaborative effort of scientists worldwide,
a growing Grant and Fellowship program and most recently the introduction
of Therapeutics Initiative that will move research from the lab to clinical
trials more quickly. Since 1997, HDSA's commitment to research has grown
from $183,000 to more that $4 million in the coming year. The answers
are out there and researchers like Dr. Raymond and Dr Hayden are just
steps away from solving the HD puzzle.
Now more than ever, we need your help to continue to fund promising research
like that published in Neuron. Please call the HDSA national office at
800-345-HDSA to find out how you can help to make this the last generation
with HD.
For more information about Huntington's Disease Society of America call
(800) 345-HDSA or visit our web site at www.hdsa.org.
STANFORD RESEARCHERS GAIN NEW INSIGHT INTO TREATMENT OPTIONS
FOR HUNTINGTON DISEASE
Stanford University Medical Center researchers have discovered what they
believe may be a potential TREATMENT FOR Huntington disease. By enhancing
the brain's natural protective response to the disease, researchers were
able to alleviate the uncontrollable tremors and prolong the lives of
mice that were artificially carrying the gene that causes HD. Their finding
suggests that a similar treatment strategy may be effective in humans.
"This is exciting because it has implications for therapy,"
said Lawrence Steinman, MD, professor of neruological sciences and pediatrics,
and senior author of the study published in the February 2002 issue of
Nature Medicine.
In their research, investigators injected the compound "cystamine"
into HD mice. They were expecting to see the compound have a direct effect
on the process of the development of toxic protein aggregates in the brain.
These aggregates are known to speed up brain cell death, and play a critical
role in the progression of the disease. However, while they were expecting
one result, they actually got a different, unexpected reaction.
Cystamine had no impact on the process of protein aggregation. Instead,
the researchers found that mice treated with cystamine had higher levels
of three particularly interesting genes, all of which are known to produce
proteins that play a protective role in the brain. These same proteins
- known as "neuroprotective proteins" - were also found at increased
levels in the brain of human Huntington's patients. This finding suggested
that the brain makes an unsuccessful attempt to protect itself against
Huntington disease. "It seems the brain under attack has a number
of defense mechanisms turned on to sop up toxic brain proteins, lead them
away to digestive compartments, and out of the neuron," Steinman
said. "This allows the neuron to survive, which is important since
mammalian brains are bad at regenerating neurons."
Can you translate that for me?
Based on this study, researchers believe that Huntington disease causes
certain proteins to be produced in affected brain cells to try and protect
them against the effects of HD. These proteins, known as "neuroprotective
proteins" act like bouncers at a bar. First, they attach themselves
to the toxic protein huntingtin. Then they drag the toxic huntingtin out
of the nucleus of the cell (the brain cell's control centre), and take
it into the body of the cell. From there they drag the huntingtin to a
place in the cell where enzymes "eat" the toxic huntingtin,
and destroy it. However, enough huntingtin builds up that even the neuroprotective
proteins can't completely stop, only slow down, the process leading to
the death of the brain cells.
By using cystamine, Dr. Steinman and his team "boosted" the
brain's natural defences, and this is what caused the positive effect
in the mice.
Though these findings suggest that cystamine could someday offer hope
to patients with Huntington disease, the quest for other, potentially
better compounds, will continue. "In recent years, other compounds
have also been reported to extend the lives of mice suffering from Huntington's,
Steinman said. "Perhaps multiple treatment in combination would have
even greater benefits."
Marcela Karpuj, primary author of the study, is optimistic about the
results. "I think this is very exciting," she said. "In
the future, treatments to raise the levels of neuroprotective proteins
could be given to humans and could be therapeutic for other neurodegenerative
diseases as well."
Acknowledgement: SM/Office of News and Public Affairs,
Stanford University, California.
Reprinted: "Horizon" No. 104, Spring 2002, Huntington Society
of Canada
The Huntington Society of Canada's NAVIGATOR Coalition steering committee
is pleased to announce that Dr. Ray Truant of McMaster University in Hamilton,
Ontario has been awarded a NAVIGATOR Coalition Grant for his research,
entitled Analysis of the huntingtin Nuclear Export Signal.
Dr. Truant's laboratory specializes in studying how proteins are regulated
in human cells, specifically, how and why proteins are allowed to go in
or out of the nucleus of a cell. The grant will go towards Dr. Truant's
work in understanding how and why the toxic protein huntingtin (created
by the mutant gene that causes Huntington disease) enters the nucleus
of brain cells, and to find out what effect, if any, preventing huntingtin
from entering the nucleus of a brain cell has on the process of cell death
in Huntington disease.
This study will be conducted "in culture", meaning at the cellular
level only. This is a way for researchers to quickly and precisely figure
out if what they observe "in culture" is important enough for
further study in mice, as well as to determine the best way to proceed
with the design of drugs. For example, if excluding huntingtin from entering
the nucleus of a cell has the ability to extend the life of a cell exposed
to huntingtin "in culture", then it could be later tried in
HD mouse models. If this approach proves successful in the mouse model,
there is potential for the development of a therapeutic approach in humans.
Dr. Truant will be able to actually see how huntingtin moves into the
nucleus of a living brain cell by using a very sophisticated microscope,
built in part by the Huntington Society's NAVIGATOR Coalition grant. This
microscope, one of a kind in Canada, will allow researchers to actually
watch different proteins, including the toxic huntingtin, moving and working
in brain cells. This work will literally give Dr. Truant a new window
into understanding why brain cells die in Huntington disease, and how
this cell death can be prevented from happening.
The researchers who evaluated Dr. Truant's grant proposal on behalf of
the Society were extremely impressed with the proposed study, and excited
about the potential for the results of the study as it relates to Huntington's
research, as well as its potential to be applied to other, related neurodegenerative
disorders. - SM
Can you translate that for me?
Every cell in the human body - including brain cells - is made up of
a number of different parts. The part of the cell that controls everything
that goes on in the cell is called the nucleus.
In Huntington disease, the gene that causes the disease produces a toxin
protein called huntingtin. This protein is produced in brain cells in
key parts of the brain - the parts that control movement, emotion, and
cognitive ability - and is normally essential for healthy brain cells.
However, if huntingtin becomes altered or mutated, like in someone with
Huntington disease, the protein becomes toxic.
Once the toxic protein is produced in the cell it does a couple of things:
it bunches up and creates little clumps in the cell, called protein aggregates;
and it also tries to get into the cell's control centre, the nucleus.
Once inside the nucleus, it bunches up and creates protein aggregates
there as well.
Researchers know that these protein aggregates speed up the death of
brain cells. What they don't know for sure is whether it's the aggregates
in the brain cell, or the aggregates in the nucleus of the brain cell,
or both, that cause cell death. But since the nucleus is the most important
part of the cell, it makes the most sense to start there first.
The nucleus doesn't let just anything in. It manages everything that
happens in the cell, and it can call on different things in the nucleus
and in the cell to help it control everything that goes on. The nucleus
is like the coach of a hockey team, putting certain players on the ice
at key points in the game, and keeping others on the bench.
Based on previous research, Dr. Truant knows that there is something called
a "nuclear import signal" in other proteins that stick to the
toxic huntingtin, and then help the huntingtin get into the nucleus. He
is trying to figure out whether there is a way to interfere with this
signal, and stop the toxic huntingtin from getting into the nucleus in
the first place. If he can stop the huntingtin from getting into the nucleus,
he can then wait and see if the protein aggregates in the rest of the
cell cause any problems in how the cell functions. In either case, researchers
will gain a better understanding of brain cell death in Huntington disease,
and new ideas about how to prevent the brain cell death from happening
in the first place. - SM
The Huntington Society of Canada's NAVIGATOR Coalition research programme
is supported by the following funds:
Founding Partner: The Geoffrey H. Wood Foundation. Leadership Partners: AGF Group of Funds; George Weston Ltd.;
McKeil Marine Ltd.; The Joseph S. Stuaffer Company; TELUS Community
Connections. Family Fund Partners: Bezeau Family Fund; Bloom Family Fund;
Rick and Norma Brock Fund; Chaplin Family Fund; Cranston-Dorr Family
Fund; Sylvia Hickson Family Fund; Sterling Family; Fund; Wright Family
Fund.
Acknowledgement: "Horizon" No. 104, Spring
2002, Huntington Society of Canada.
By Adam McLean, Counselling Co-ordinator, Carers NSW
Caring and Guilt
One of the most common emotions that carers express when speaking of
their caring situation is guilt. What is it about this word that has so
much meaning for carers and is so often talked about. If you have to think
about what the word guilt means to you, how would you describe it? It's
a tough one and even reading the word can evoke a strong reaction within.
For some carers the word guilt is difficult to describe or speak about
as they believe they are being disloyal or don't have the right to express
this feeling. Guilt can be healthy in that it can be a barometer to gauge
the feeling we have when we do something that we know is unfair or wrong.
Even just thinking about doing or not doing something can cause a feeling
of guilt to arise. Healthy guilt keeps us from doing something that can
be inconsiderate or unreasonable and is controlled by our conscience.
Unhealthy guilt is when we expect perfection in everything we do, or we
want to accomplish the impossible, or feel responsible for others, or
when we don't live up to our own expectations or rules that we have mapped
out for ourselves. We can set ourselves up to expect too much, not only
from ourselves, but also from others.
Some of the factors that can influence our reaction to guilt are based
on values that are passed on, such as beliefs, morals, rules, religion,
social and cultural traditions, and so on. Often it is good to review
your values occasionally to see if they are still valid. Guilt can come
attached with many emotions such as resentment, responsibility, abuse,
depression and anger.
The next time you are feeling guilty, why not take some time out and
explore what is happening to you and the reasons for your guilt. Here
are some things you might want to consider:
· What have you done or failed to do?
· Should you feel guilty?
· What were the circumstances that contributed to your feeling
guilty?
· Are you making unreasonable demands on yourself?
· Do you expect yourself to be the same all the time in your
caring role?
· Do you give yourself permission to be you?
· Are you a perfectionist?
· Are your expectations of yourself unreasonable?
· Do you live according to your beliefs?
By reviewing one or some of these questions you are checking the validity
and explanation of your behaviour that has contributed to your feeling
of guilt.
Another aspect in dealing with guilt is recognising the language that
is used. For example the use of the word 'should' in this statement, "I
should have done better ", doesn't offer a choice - it is a
self-criticism. By replacing 'should' with 'could', you offer yourself
a choice: "I could have done better ". Other words to recognise
are 'must', and 'ought'. Try replacing them with 'might' or 'could'. Using
these words gives you an alternative. Sounds easy, although it can be
difficult in reality - but have a go.
Often carers speak of a feeling that guilt is being imposed onto them
by the person they care for. This is often seen as the person getting
his or her own way, or being manipulative. This can happen for many reasons.
It can be used to hide the unhappiness, sadness, hurt, pain, frustration
or anger of the person being cared for. More often they will place the
focus of these feelings onto others as a way of avoiding their own feelings.
This form of behaviour can often leave you, the carer, feeling guilty.
When you do feel guilty or have negative feelings, here are some simple
ways of looking after you:
· Accepting that you have needs and they are important is often
the first step. Negative feelings, like guilt, can be destructive. If
you don't address them, you are more likely to become unwell or in need
of care yourself.
· Be honest with yourself and your expectations. Review your situation:
Do you need help or a break? Is respite an option for you?
· When you make mistakes or feel that you haven't done everything
that you wanted, learn from this and look at what you have achieved. Is
it worth getting upset or loosing sleep over?
· Having strong feelings is normal and acceptable - it is to be
expected in the caring role. What's important is how these feelings affect
you in your caring relationship and your relationship with others. (With
guilt - is it healthy guilt or unhealthy guilt? - you will know).
With guilt - is it healthy guilt or unhealthy guilt? You will know.
There is no way of preventing the feeling of guilt or the myriad of negative
feelings from arising. But talking things through can help. The Carer
Resource Centre staff are here to talk things through with you when you
may feel the need to off-load. Our After Hours Carers Line is also available
to you seven days a week, especially over the festive season, when many
services close. You can talk to someone who understands on 1800 242 636.
GUIDELINES FOR MEETING THE NUTRITIONAL NEEDS OF PEOPLE
WITH HUNTINGTON'S DISEASE
Karen Keast - Dietitian NSW HD Outreach
10 STEPS TO GOOD NUTRITION
1. Eat Frequent Meals and Snacks
AS WELL as breakfast, lunch and dinner include morning tea, afternoon
tea and supper.
HAVE double serves of meals and desserts.
2. Ensure All Food is Soft and Moist
AVOID foods which are hard and brittle and more difficult to swallow
such as chips, corn chips, nuts, hard lollies etc.
ADD extra gravy and sauces to savoury foods and custard and creams to
sweet foods.
3. Make Every Mouthful Count
CHOOSE nutritious energy dense food and drinks, eg milk or fruit juice
rather than tea, coffee or clear soup.
eg cake and cream rather than a plain biscuit.
4. Enrich the Food You Eat
ADD foods rich in protein and energy to those you already eat and drink,
eg add cream to fruit and margarine or sour cream to vegetables.
5. Try to Include a Protein Food with Each Meal
SUCH AS meat, chicken, fish, egg, cheese, milk, custard or legumes.
6. Have Ready-to Eat High Energy Snacks Handy
eg Yoghurts, fruche, cream cake, fruit and custard.
7. Supplement Your Diet
USE fortified drinks such as high protein milk or Sustagen to boost
your energy intake.
8. Enjoy Your Meals and Eat a Variety of Foods
VARY your meals so eating does not become a chore.
9. Maintain a Calm and Relaxing Environment For Meals
MINIMISE all distractions, ie turn the TV and radio off.
ALWAYS sit upright for meals and for at least a half-hour after meals.
ALLOW plenty of time for meals.
EAT slowly.
AVOID eating and drinking at the same time.
10. Monitor Your Weight
CONTACT your doctor or dietitian if you are concerned.
NUTRITIONAL SUPPLEMENTS
WHAT ARE THEY?
Supplements are special food products or powders that can be used as part
of, or in addition to, your daily food intake. They can add extra energy,
protein, vitamins and minerals.
WHY SHOULD I USE THEM?
Supplements are helpful for people who -
Have lost weight
Have difficulty in maintaining their weight
Have a poor appetite
Are not eating enough food
WHEN COULD I USE THEM?
Between meals
As part of a meal
Any time you want to eat or drink
SUGGESTED SUPPLEMENTS FOR YOUR USE
High Protein Milk Recipe
1000ml (1 litre) full cream milk and 1 cup skim milk powder OR
150ml (small glass) full cream milk and 2 tablespoons skim milk powder
Add milk powder to milk and whisk until dissolved
HIGH PROTEIN MILK CAN BE USED WHEN EVER YOU NORMALLY USE MILK
Compiled by the Dietitians Association of Australia
NSW Gerontology Interest Group.
ENRICHING WITH PROTEIN AND ENERGY
Breakfast Cereals
Use high protein milk or Sustagen
Make porridge on milk or Sustagen rather than water
Add sugar or honey
Toast, Bread, Muffins, Crumpets
Spread margarine or butter thickly
Use smooth peanut butter, marmalade, jam, honey
Use avocado or mayonnaise
Sandwiches
Spread margarine or butter thickly
Add an extra slice of meat or cheese
Add mayonnaise, relish, creamed cheese, avocado
Vegetables
Add margarine, butter, oil, cheese, sour cream, white sauce
Add milk powder or cream to mashed vegetables
Fruits
Add custard, ice cream, gelato, cream, yoghurt
Add sugar, glucose syrup or honey
Add to milk drinks
Soups and Sauces
Add milk powder, cream, sour cream, eggs, grated cheese
Use cream soups instead of broths and consommés
Make soup on milk rather than water
Drinks
Encourage milk and juice based drinks in preference to water, tea or
coffee
Use high protein milk for milk drinks
Add honey, malt, glucose syrup, flavoured toppings
Add Cocoa, flavoured drink powder, ice-cream, fruit
Use commercial supplements
Acknowledgements to : Dietitians Association of Australia
NSW Gerontology Special Interest Group
QUICK SIMPLE MEAL SUGGESTIONS
Snack Suggestions
Breakfast cereal with evaporated or high protein milk and canned fruit
and top with cream.
Canned spaghetti, baked beans, creamed corn on buttered toast with cheese.
Canned salmon, tuna or sardines mixed with mayonnaise on buttered bread.
Canned cream soups made on evaporated milk or with added cream. Serve
with buttered toast, bread or a bread roll.
Eggs - boiled, poached or fried, served with buttered toast and top
with cheese.
Scrambled egg made with extra milk or cheese, served on buttered toast
or bread.
Omelette, eg cheese and ham, served with buttered toast or bread.
French toast (bread and margarine, soaked in egg then fried).
Potatoes - baked or microwaved until soft and filled with sour cream,
cheese, mashed baked beans or minced meat.
Pasta cooked with cream sauces.
Wholemeal sandwiches with fillings of choice include meat, chicken,
canned fish, cheese, baked beans, smooth peanut butter or egg.
SUGGESTIONS FOR SANDWICH FILLINGS
Choose wholemeal bread and spread liberally with margarine. Remove
crusts if required.
Grated cheese and pickles
Grated cheese and vegemite.
Salmon or tuna with mayonnaise
Smoked salmon with creamed cheese
Tuna and creamed corn
Mashed sardines and tomato sauce
Curried egg with mayonnaise
Mashed avocado with lemon juice, pepper and sour cream
Shaved ham and cream cheese
Shaved chicken, grated cheese and mashed avocado
Shaved chicken, camembert cheese and cranberry sauce
Shaved roast beef and mustard
Mashed baked beans and grated cheese
Smooth peanut butter with honey, jam or mashed banana
Smooth peanut butter and cream cheese
Hommus
Canned spaghetti, mashed baked beans or creamed corn with
grated cheese buttered toast with cheese
(Further ideas for Meeting the Nutritional Needs of People with HD in
next Newsletter.)
Aladdin's Bazaar - 26th May at Pulse, Griffith Road, Eastern Heights,
Ipswich. Please refer back to your February Newsletter for further
details. Funds have been received from John Nugent, O.A.M., Mayor of
Ipswich, Cr. Paul Pisasale, Cr. David Morrison, Cr. Heather Morrow, Cr.
Andrew Antoniolli and Cr. Denise Hanly all of Ipswich City Council.
We sincerely thank the above sponsors for supporting the Aladdin's Bazaar.
The Mayor and Councillors of Ipswich City Council also extended their
congratulations to Hedy and Patrick for their fundraising efforts
and continued support of the Association.
Rotary Raffle - Tickets are not yet available however the prize
is a trailer plus merchandise. Tickets are $2.00 each and for each ticket
sold the Association receives $1.00. Please support this combined fundraiser
between the Rotary Club of Acacia Ridge and the HD Association. Tickets
will be available from the HD office in May.
We are looking for volunteers to assist with selling tickets at the Caravan
Show - if you can help please ring Barbara at the office.
Community Assistance - Recently we have received, and gratefully acknowledge
here, major financial assistance from the following donors:
JW Bell & Associates
B. Gillespie
GR Phillips
Wagstaff Piling Pty Ltd
The Sherwood Forest Runners have been at it again - raising funds
through donations made by runners in their Group. The Huntington's Disease
Association was again nominated their charity for the year and we recently
received $500.00 due to their efforts.
Our sincere thanks to the runners for their generosity.
The printing of this Newsletter
was done by courtesy of
SOUTHPORT PRINTING COMPANY
19 Production Avenue, Ernest, Q. 4214
Tel.: (07)5594 9911
FOR YOUR DIARY
May 21 Management Committee Meeting - 6.00 pm at HD Centre, Annerley May 26 Aladdin's Bazaar at Pulse, Griffith Road, Eastern Heights,
Ipswich
June 6 Townsville Family Support Meeting - 7.00 pm at 59 Cambridge
St., Vincent June 11 Bundaberg Family Support Meeting June 18 Management Committee Meeting - 6.00 pm at HD Centre, Annerley
July 4 AGM Townsville Family Support Group - 7.00 pm at 59 Cambridge
Street, Vincent July 16 Management Committee Meeting - 6.00 pm at HD Centre, Annerley